Cytokinetics Inc balance sheet

At the end of fiscal 2025, Cytokinetics Inc had total assets of $1.42bn, total liabilities of $2.08bn and shareholders' equity of −$660m. It held $123m in cash against $999m of debt: net debt of $877m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Cytokinetics Inc: balance sheet, annual
Fiscal year	2009Dec 2009	2010Dec 2010	2011Dec 2011	2012Dec 2012	2013Dec 2013	2014Dec 2014	2015Dec 2015	2016Dec 2016	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025	LTMJun 2026
Cash and equivalents	26	18	19	15	20	20	65	67	125	42	36	83	113	66	113	95	123	255
Receivables	—	—	—	—	—	—	—	0	1	2	5	4	52	0	1	17	18	24
Inventory	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0	0
Total current assets	—	73	51	76	79	131	113	159	274	208	234	474	536	795	628	1,108	917	1,208
Total assets	—	78	53	78	83	133	115	170	295	211	290	534	841	1,015	824	1,402	1,425	1,925
Accounts payable	—	1	1	2	4	1	2	4	5	4	8	8	21	26	22	20	22	21
Deferred revenue (current)	—	0	—	0	15	17	21	8	0	0	—	—	—	—	0	52	2	2
Total current liabilities	—	7	5	7	27	24	32	33	32	22	26	31	72	85	103	180	202	181
Short-term debt	—	—	—	—	—	—	0	3	0	3	0	0	—	1	10	12	41	27
Long-term debt	—	—	—	—	—	0	15	27	32	40	45	46	47	64	58	93	246	248
Total debt	0	0	0	0	0	0	15	30	32	42	45	46	47	650	639	620	999	276
Total liabilities	—	7	5	7	29	41	47	76	185	185	301	420	597	1,123	1,211	1,537	2,084	2,098
Shareholders' equity	101	71	48	70	54	92	69	94	110	26	−11	113	244	−108	−386	−135	−660	−173
Net debt (negative = net cash)	−26	−17	−19	−15	−20	−20	−50	−37	−93	0	9	−37	−65	584	526	525	877	20
Shares outstanding	—	—	—	—	31m	39m	40m	41m	54m	55m	59m	71m	85m	95m	102m	118m	123m	—

US$ millions unless shown otherwise. Fiscal quarters.

Cytokinetics Inc: balance sheet, quarterly
Quarter	2024 Q3Sept 2024	2024 Q4Dec 2024	2025 Q1Mar 2025	2025 Q2Jun 2025	2025 Q3Sept 2025	2025 Q4Dec 2025	2026 Q1Mar 2026	2026 Q2Jun 2026
Receivables	0	17	2	8	2	18	7	24
Inventory	—	—	—	—	—	0	0	0
Total current assets	1,019	1,108	956	887	977	917	839	1,208
Total assets	1,436	1,402	1,264	1,226	1,437	1,425	1,273	1,925
Accounts payable	12	20	14	16	22	22	25	21
Deferred revenue (current)	—	52	52	1	2	2	2	2
Total current liabilities	110	180	160	131	142	202	199	181
Short-term debt	12	12	13	14	17	41	45	27
Long-term debt	93	93	92	159	159	246	247	248
Total debt	105	105	105	173	176	288	292	276
Total liabilities	1,450	1,537	1,530	1,594	1,958	2,084	2,100	2,098
Shareholders' equity	−14	−135	−266	−369	−521	−660	−827	−173
Shares outstanding	—	118m	—	—	—	123m	—	—

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: CYTK vs RXRX ABCL vs CYTK CYTK vs WVE CUVL vs CYTK

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Cytokinetics Inc's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Cytokinetics Inc.